関連する実験動画
Updated: Sep 1, 2025

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
9.6K
p53の喪失後の有序で決定的ながんゲノム進化
Timour Baslan1, John P Morris1,2,3, Zhen Zhao1,4
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nature
|August 17, 2022
まとめ
驚くべきことに 腫瘍抑制剤p53の喪失は 臓がんの発症の過程で 予測可能な進化の経路をたどります この発見は,TP53変異性がんの新たな治療目標を提供します.
科学分野:
- 腫瘍学
- 遺伝学
- ゲノミクス
背景:
- p53の無活性化がヒトの癌でよく見られる現象で,ゲノムの不安定性を促進する.
- 腫瘍形成におけるp53喪失後の正確なゲノム進化パターンは十分に理解されていません.
研究 の 目的:
- 管腺がんにおけるp53不活性化後のゲノム進化パターンを調査する.
- P53の喪失が,がんの発症中に予測可能なまたは混沌としたゲノム変化につながるかどうかを判断する.
主な方法:
- 早期のp53異胞性喪失による臓管腺癌のマウスモデルを使用した.
- 単細胞配列決定と in situ 遺伝子型決定を用いて,p53不活性化からがんへのゲノム進化を追跡した.
- 腫瘍前および腫瘍前進行中のゲノム変化とともに,組織学的段階を分析した.
主要な成果:
- 臓がんの進行におけるp53不活性化は,決定的な4段階のゲノム進化をたどる:ヘテロジゴシティの喪失,デレーション,ゲノムの倍増,および増強/増幅.
- 削除イベントは,全体的なゲノム異質性にもかかわらず,特定の経路をターゲットにして固定されます.
- ゲノム進化の各段階は 異なる組織学的段階と相関しています
結論:
- p53の無活性化が 遺伝的カオスへの入り口であるだけでなく 予測可能なゲノム進化パターンを 誘導する可能性があります
- これらの決定的パターンを理解することで,TP53変異がんの新たな治療戦略が明らかになる可能性があります.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Loss of Tumor Suppressor Gene Functions
5.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

